Healthcare Media & Clinician Networks · Advertiser / Brand
Angelini Pharma
German pharmaceutical subsidiary focused on brain and consumer health.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Angelini Pharma Deutschland GmbH
- Entity type
- COMPANY
- Headquarters
- Germany
- Company size
- 50–200
- Market cluster / sector
- Healthcare Media & Clinician Networks
- Market role
- Advertiser / Brand
- Official website
- angelinipharma.de
What Angelini Pharma does
The company creates value by commercialising prescription medicines and consumer healthcare products in Germany under the Angelini Pharma portfolio. It combines pharmaceutical sales, channel management and medical-market education with proprietary digital tools that improve pharmacy relationships, operational coordination and patient engagement. The core economic engine is product distribution through healthcare channels, while digital platforms deepen access, retention and market visibility.
Category differentiation
This company is a German pharmaceutical operating subsidiary, not a standalone software vendor or advertising technology platform. Its digital products support pharmacy engagement and health education rather than constituting its primary business.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Angelini Pharma Deutschland GmbH is the German subsidiary of Angelini Pharma S.p.a., a private pharmaceutical company within Angelini Industries. In Germany, it markets prescription and consumer healthcare products with a stated focus on brain health and consumer health. The company is not an adtech or software vendor; it is a pharmaceutical operating business that also uses digital assets to support channel relationships and health education. Its revenue comes primarily from pharmaceutical and consumer health product sales through healthcare and pharmacy channels, supported by market-specific distribution and reimbursement structures. The company’s proprietary digital products play supporting roles: Angelini Pharma PLUS+ strengthens pharmacy engagement through training and order visibility, while Harmonia Mentis functions as an educational content hub for patients, caregivers and healthcare professionals, reinforcing disease awareness and brand engagement rather than acting as core standalone revenue drivers.
Business model & monetisation
Angelini Pharma Deutschland monetises primarily through one-off product sales of prescription medicines and consumer healthcare products via wholesale, pharmacy and healthcare channels. Pricing is governed by standard pharmaceutical commercial mechanics, including distribution margins and reimbursement-linked market access where applicable. Its digital assets are support layers rather than core paid software products: PLUS+ strengthens pharmacy retention and ordering relationships, and Harmonia Mentis supports awareness and demand generation for brain health categories.
- Prescription pharmaceutical sales
- One-time Sale
- Consumer healthcare product sales
- One-time Sale
- Digital pharmacy enablement platform
- Patient education content hub
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Angelini Pharma
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
30 Jahre Tag der Epilepsie: Menschen mit Epilepsie fordern mehr Offenheit im Beruf und Alltag
Recorded impact score: 2/5
Zum 30. Tag der Epilepsie macht Angelini Pharma auf Wissenslücken aufmerksam und setzt sich für mehr Offenheit und einen selbstverständlicheren Umgang mit Epilepsie ein.
Explore company relationships
Questions about Angelini Pharma
What is Angelini Pharma?
Angelini Pharma is the German subsidiary of Angelini Pharma S.p.a., focused on prescription and consumer healthcare products, especially in brain health and consumer health.
Who uses Angelini Pharma?
Its direct customers include pharmacists, pharmacy businesses, healthcare professionals and distribution partners, while patients and caregivers use its educational content platforms.
How does Angelini Pharma make money?
It makes money primarily from selling prescription medicines and consumer healthcare products through regulated healthcare and pharmacy channels.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
14 publicly documented primary sources and citations linked across the market graph.
Continue your research on Angelini Pharma
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.
Unlock full intelligence profile, ownership & live market signals